Free Trial

IMAC Q2 2023 Earnings Report

IMAC logo
$1.21 +0.09 (+8.04%)
(As of 12/20/2024 05:40 PM ET)

IMAC EPS Results

Actual EPS
-$1.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IMAC Revenue Results

Actual Revenue
$1.34 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IMAC Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

IMAC Earnings Headlines

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
See More IMAC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IMAC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IMAC and other key companies, straight to your email.

About IMAC

IMAC (NASDAQ:BACK) owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

View IMAC Profile

More Earnings Resources from MarketBeat

Upcoming Earnings